Navigation Links
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
Date:3/4/2013

, Spain, Revenue Forecast ($m), 2011-2019 30
Figure 23: Idiopathic Thrombocytopenic Purpura, Japan, Revenue Forecast ($m), 2011-2019 31
Figure 24: Idiopathic Thrombocytopenic Purpura, Total Market, Average Annual Cost of Therapy (%), 2011-2019 32
Figure 25: Idiopathic Thrombocytopenic Purpura, Treatment Usage Pattern ('000), 2011-2019 33
Figure 26: Idiopathic Thrombocytopenic Purpura, Pipeline Overview 35
Figure 27: Idiopathic Thrombocytopenic Purpura, Pipeline, Phase I by Therapeutic Class 36
Figure 28: Idiopathic Thrombocytopenic Purpura, Pipeline, Phase II Molecule Comparison 37
Figure 29: Idiopathic Thrombocytopenic Purpura, Pipeline, Phase III Molecule Comparison 39
Figure 30: Idiopathic Thrombocytopenic Purpura, Pipeline by Therapeutic Class 40
Figure 31: Idiopathic Thrombocytopenic Purpura, Pipeline by Molecule Type 40
Figure 32: Idiopathic Thrombocytopenic Purpura, Pipeline by Mechanism of Action 41
Figure 33: Myelodysplastic Syndrome, Total Market, Revenue Forecast ($m), 2011-2019 45
Figure 34: Myelodysplastic Syndrome, US, Revenue Forecast ($m), 2011-2019 46
Figure 35: Myelodysplastic Syndrome, UK, Revenue Forecast ($m), 2011-2019 46
Figure 36: Myelodysplastic Syndrome, France, Revenue Forecast ($m), 2011-2019 47
Figure 37: Myelodysplastic Syndrome, Germany, Revenue Forecast ($m), 2011-2019 47
Figure 38: Myelodysplastic Syndrome, Italy, Revenue Forecast ($m), 2011-2019 48
Figure 39: Myelodysplastic Syndrome, Spain, Revenue Forecast ($m), 2011-2019 48
Figure 40: Myelodysplastic Syndrome, Japan, Revenue Forecast ($m), 2011-2019 49
Figure 41: Myelodysplastic Syndrome, Total Market, Average Annual Cost of Therapy (%), 2011-2019 50
Figure 42: Myelodysplastic Syndrome, Treatment Usage Pattern ('000), 2011
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
2. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
3. Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC
4. Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections
5. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
8. FDA Grants Orphan Drug Status To Eisais Lenvatinib
9. Lentigen Receives U.S. Orphan Drug Designation for Novel Gene Therapy for glioblastoma multiforme
10. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
11. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... quantum dot market report analyzes the ecosystem of the quantum ... includes medical devices, display, and others. The others segment consists ... QD laser, and transistor. The application segment covers the market ... report also provides the geographic view for major regions like ... , Asia-Pacific (APAC), and Rest ...
(Date:9/2/2015)... Colo. , Sept. 2, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in Boston.  The public is welcome ... on the Array BioPharma website.Event: Wells Fargo Securities ... Thursday, September 10, 2015Time:  , 10:20 a.m. Eastern ...
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a ... systems for the eye, today announced that its Board of ... Company,s Board. Mr. Wall was formerly the ... -based investment firm, for more than nine years. Mr. Wall ... chair of the Corporate Governance Committee and member of the ...
Breaking Medicine Technology:Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2William P. Wall Appointed to STAAR Surgical Board of Directors 2
... 17, 2012  Tengion, Inc. (NASDAQ: TNGN ), ... recently completed a successful Pre-IND meeting with the U.S. ... program, the Neo-Kidney Augment™. The FDA and the Company ... study program required to support an Investigational New Drug ...
... Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" ... Distribution Specialists, LLC ("HDS") are pleased to announce that ... and Hemostasis Summit of North America (the "THSNA") to ... Chicago.  "Participation as an official exhibitor ...
Cached Medicine Technology:Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 2Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 3Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 4Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 5Sunpeaks Ventures to Exhibit Clotamin at the first-ever Thrombosis and Hemostasis Summit of North America 2
(Date:9/3/2015)... ... ... types of people who have a hard time gaining weight , it seems that ... those that have a fast metabolism. In order to help those people who have a ... slowing down metabolism. , The first thing to do is to space out meals. When ...
(Date:9/3/2015)... ... , ... James Earl Jones will be hosting an upcoming VOICES IN AMERICA ... will introduce a segment that discusses why it is important for the workplace to ... fostered in any working environment. , Employers are out billions of dollars year after ...
(Date:9/3/2015)... ... September 03, 2015 , ... The partnership will ... and technical support services to promote LodonalTM in Nigeria. The distribution will become ... efficacy and safety of the product. , Managing Director, Fidson Healthcare Plc, Dr ...
(Date:9/2/2015)... ... , ... Leah Binder, MA, MGA, president and CEO of ... will offer the keynote address at the upcoming meeting of the ACO and ... Florida, at the Innisbrook Resort and Golf Club. For an agenda and registration, ...
(Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... ... nominations to determine who among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, ... nation’s health care. This year, that process led the magazine to tap the ...
Breaking Medicine News(10 mins):Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3
... need to make tough choice on whether it,s worthwhile, ... Implanted defibrillators don,t seem to provide any particular ... study finds. , A defibrillator can provide a lifesaving ... be fatal. But it generally does nothing for heart ...
... common elective medical proceduresEAGAN, Minn., March 16 Consumers ... quality information through Care Comparison(R), a new online tool ... Minnesota. Care Comparison allows nearly two million Blue Cross ... well as quality, safety and accessibility information for dozens ...
... - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... of investigators (lead by Professor Mirjana Stojiljkovic) from ... Stankovic", University of Belgrade, Serbia, (IBISS group) introduced ... sclerosis (MS), a severe, currently incurable, human disease. ...
... Dr. Eleanor Rogen of the University of Nebraska ... located in Omaha, Nebraska, have identified the triggering ... begin. Preventium http://www.preventium.org is a recently ... risk for breast and prostate cancer. Ercole Cavalieri, ...
... SB 1022/HB 675 Bill Would Provide Access to ... Failure Patients Who QualifyTALLAHASSEE, Fla., March 16 ... Florida) praised Senator Thad Altman and Representative Ritch ... provide access to secondary health insurance for Florida,s ...
... International, Inc.,(Nasdaq: DATA ), a technology and ... trials industry, today announced its operating,results for the fourth ... Revenue for the fourth quarter of 2008 ... period of 2007. Gross profit margin,improved to 80% for ...
Cached Medicine News:Health News:Defibrillator May Not Help Many With Heart Failure 2Health News:Defibrillator May Not Help Many With Heart Failure 3Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 2Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 3Health News:Hard to Treat Diseases (HTDS) Releases experimental results in the treatment of (MS) Multiple Sclerosis 2Health News:The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring 'Common Sense' Legislation Widely Hailed as 'Good for Patients, Good for Taxpayers, Good for Florida' 2Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 2Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 3Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 4Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 5Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 6Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 7Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 8Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 9Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 10
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Plus Sterile Isopropyl Alcohol ... primarily used as a ... administering injections. They are ... AAMI/ANSI/ISO 11137 standards to ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
Medicine Products: